Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
December 18, 2018
Entrada Therapeutics Raises $59 Million Series A to Advance Intracellular Biologics Platform
December 12, 2018
Magnetic Insight Raises $18M to Support Commercial Growth of Magnetic Particle Imaging in Cell Therapy, Vascular and Oncology Applications
December 12, 2018
Cell Therapy Industry Pioneer, Gwendolyn Binder, Ph.D., to Join Cabaletta Bio Leadership Team
December 10, 2018
Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O™ to Treat Opioid Use Disorder
December 10, 2018
Arvinas Presents Preclinical Data on Protein Degrader, ARV-471, at the 2018 San Antonio Breast Cancer Symposium (SABCS)
December 7, 2018
Millendo Therapeutics Announces Successful Merger Completion
December 6, 2018
Viveve Announces Positive 12-Month Data from Stress Urinary Incontinence Feasibility Study
December 3, 2018
Aprea Therapeutics Presents Results From Phase Ib/II Clinical Study of APR-246 and Azacitidine (AZA) in Patients with TP53 Mutant Myelodysplastic Syndromes (MDS) at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego
December 1, 2018
Aprea Therapeutics Closes EUR 50 Million Financing
November 20, 2018
Sandoz and Pear Therapeutics Announce Launch Of reSET® For Treatment Of Patients With Substance Disorder
« Previous Page
1
…
71
72
73
74
75
…
119
Next Page »